Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESR 1150 CL in Healthy Volunteers (Phase 1)
NCT02209688Phase 1Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2000
- Primary completion
- Mar 2000
01
Overview
Phase 1, randomised, double-blind trial of ESR-1150-CL in Stress urinary incontinence (SUI) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of patients with adverse events at 30 days, Area under the curve at 24 hours and 14 more. Started Feb 2000; status: terminated.
02
Drugs
ESR-1150-CL
03
Conditions
Stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT02209688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209688.